Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021260

Expand all

AVINZA (MORPHINE SULFATE)
30MG
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: AVINZA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021260
Product Number: 001
Approval Date: Mar 20, 2002
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

AVINZA (MORPHINE SULFATE)
45MG
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: AVINZA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 45MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021260
Product Number: 005
Approval Date: Dec 18, 2008
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

AVINZA (MORPHINE SULFATE)
60MG
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: AVINZA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021260
Product Number: 002
Approval Date: Mar 20, 2002
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

AVINZA (MORPHINE SULFATE)
75MG
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: AVINZA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 75MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021260
Product Number: 006
Approval Date: Dec 18, 2008
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

AVINZA (MORPHINE SULFATE)
90MG
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: AVINZA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 90MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021260
Product Number: 003
Approval Date: Mar 20, 2002
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

AVINZA (MORPHINE SULFATE)
120MG
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: AVINZA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 120MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021260
Product Number: 004
Approval Date: Mar 20, 2002
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information